bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate
CORTISPORIN (bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate) by R-Pharm US is clinical pharmacology colistin sulfate is a polypeptide antibiotic which penetrates into and disrupts the bacterial cell membrane. Approved for superficial bacterial infections of the external auditory canal, caused by organisms susceptible to the action of the antibiotics. First approved in 1971.
Drug data last refreshed 20h ago · AI intelligence enriched 1w ago
Cortisporin is a fixed-dose combination ointment containing four active ingredients: bacitracin zinc, hydrocortisone, neomycin sulfate, and polymyxin B sulfate. It treats superficial bacterial infections of the external auditory canal by combining broad-spectrum antibiotic activity against gram-positive and gram-negative organisms with anti-inflammatory corticosteroid action. The antibiotics disrupt bacterial cell membranes and protein synthesis while hydrocortisone suppresses inflammation and pruritus.
As a long-approved legacy product approaching loss of exclusivity, the brand team is likely small and focused on defensive market maintenance rather than growth initiatives.
CLINICAL PHARMACOLOGY Colistin sulfate is a polypeptide antibiotic which penetrates into and disrupts the bacterial cell membrane. Neomycin sulfate is an aminoglycoside antibiotic which inhibits protein synthesis, disrupting the normal cycle of ribosomal function. Hydrocortisone acetate is a…
Worked on CORTISPORIN at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on Cortisporin offers limited career growth due to its mature, legacy status and approaching loss of exclusivity; roles are primarily maintenance-focused rather than expansion-oriented. This position is best suited for professionals seeking stable, lower-intensity commercial work or those transitioning between high-growth products.